10 Search Results


86
Grainger Industrial 2014 2acfr sa 1 itu nd pin connector male digikey 350 10 101 00 006000 socket connector female digikey 2 5331272 3
2014 2acfr Sa 1 Itu Nd Pin Connector Male Digikey 350 10 101 00 006000 Socket Connector Female Digikey 2 5331272 3, supplied by Grainger Industrial, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/00+006000+1+10+101+2+2014+2acfr+3+350+5331272+connector+connector+digikey+digikey+female+itu+male+nd+pin+sa+socket/pm40902590-287-214-198
Average 86 stars, based on 1 article reviews
2014 2acfr sa 1 itu nd pin connector male digikey 350 10 101 00 006000 socket connector female digikey 2 5331272 3 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Boston Scientific Corporation max 6 atm
Max 6 Atm, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/10+atm+max/10__1016_slash_s0735___1097_ascii40_18_ascii41_34080___4-5103-58-65
Average 86 stars, based on 1 article reviews
max 6 atm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Pfizer Inc methoxy 3 pyridinyl methylene
Methoxy 3 Pyridinyl Methylene, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/05+1+1+1+10+11+11s+12+12r+13+13+2+2+2+3+3+3+4+4+4+5+6+7+7+8+fluoro+fluorophenyl+methyl+one+tetraen+triazatricyclo+triazol+trideca+yl/us12419876-48-9-14
Average 86 stars, based on 1 article reviews
methoxy 3 pyridinyl methylene - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

96
Dojindo Labs sensitive dcfh da kit
Sensitive Dcfh Da Kit, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/ROS+Assay+Kit+-Highly+Sensitive+DCFH-DA/10__1186_slash_s40538___025___00856___1-120-8-11
Average 96 stars, based on 1 article reviews
sensitive dcfh da kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Dojindo Labs glucose uptake assay kit red
Glucose Uptake Assay Kit Red, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/Glucose+Uptake+Assay+Kit-Red/10__21203_slash_rs__3__rs___7460929_slash_v1-52-10-14
Average 94 stars, based on 1 article reviews
glucose uptake assay kit red - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

97
Dojindo Labs liperfluo
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Liperfluo, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/Liperfluo/bio_rxiv__64898__2026__05__02__722429-197-14-15
Average 97 stars, based on 1 article reviews
liperfluo - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

99
Dojindo Labs ferroorange
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Ferroorange, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/FerroOrange/pmc13153429-248-11-12
Average 99 stars, based on 1 article reviews
ferroorange - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

93
Dojindo Labs r phycoerythrin labeling kit nh2
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
R Phycoerythrin Labeling Kit Nh2, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/R-Phycoerythrin+Labeling+Kit+-+NH-2/pmc10769852__pnas__2316964120__sapp-42-16-19
Average 93 stars, based on 1 article reviews
r phycoerythrin labeling kit nh2 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Dojindo Labs gsh gssg concentrations
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Gsh Gssg Concentrations, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/GSSG%2FGSH+Quantification+Kit+-+Oxidized%2FReduced+Glutathione+Assay/pmc06627349-138-0-10
Average 95 stars, based on 1 article reviews
gsh gssg concentrations - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Dojindo Labs ocr plate assay kit
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Ocr Plate Assay Kit, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/Extracellular+OCR+Plate+Assay+Kit/pmc11570766-246-5-10
Average 95 stars, based on 1 article reviews
ocr plate assay kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Dojindo Labs atp assay kit luminescence
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Atp Assay Kit Luminescence, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/ATP+Assay+Kit-Luminescence/pm41027938-382-6-9
Average 95 stars, based on 1 article reviews
atp assay kit luminescence - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

92
Dojindo Labs mega 8
(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of <t>Liperfluo</t> staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.
Mega 8, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10/MEGA-8/us08211379-536-0-6
Average 92 stars, based on 1 article reviews
mega 8 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

Image Search Results


(A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of Liperfluo staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.

Journal: bioRxiv

Article Title: PBRM1-VHL cooperation rewires lipid and iron metabolism to promote ferroptosis resistance in clear cell renal cell carcinoma

doi: 10.64898/2026.05.02.722429

Figure Lengend Snippet: (A) Representative flow cytometry histograms and quantification of BODIPY 581/591 C11 oxidation ratio (oxidized/reduced) in Caki-2 cells expressing vector, PBRM1, VHL, or PBRM1+VHL treated with DMSO or RSL3 (0.33 µM) for 12 hours. (B) As in (A), BODIPY 581/591 C11 oxidation ratio in RCC4 cells reconstituted cells treated DMSO or RSL3 (0.11 µM) for 12 hours. (C) BODIPY 581/591 C11 oxidation ratio in CRISPR-edited HEK293T cells (sgControl, sgPBRM1, sgVHL, sgPBRM1+sgVHL) treated with DMSO or RSL3 (0.33 µM) for 8 hours. (D-E) Representative histograms and mean fluorescence intensity (MFI) quantification of Liperfluo staining in Caki-2 (D) and RCC4 (E) cells following RSL3 treatment as in (A-B). (F) Liperfluo fluorescence as mean fluorescence intensity in CRISPR-edited HEK293T cells following RSL3 treatment as in (C). (G) Representative flow cytometry histograms of BODIPY 581/591 C11 oxidation in Caki-2 reconstituted cells treated with RSL3 (0.33 µM) ± ferrostatin-1 (Fer-1; 1 µM) for 8 h. (H) Schematic illustrating the relationship between the NAD⁺/NADH pool, NADP⁺/NADPH generation via NAD kinase, GSH/GSSG redox cycling, and GPX4-dependent detoxification of lipid peroxides. GSTs: Glutathione S-transferases; Prdxs: Peroxiredoxins. (I) Glutathione redox status (GSH/GSSG ratio) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the GSH/GSSG-Glo™ Assay. (J) Total NAD (NAD⁺ + NADH) in Caki-2 cells treated with DMSO or RSL3 (0.33 µM) for 8 hours, quantified using the NAD/NADH-Glo™ Assay. Data are presented as mean ± SD with individual replicates shown ( n = 3 biologically independent replicates for panels A, J, I; n = 4 for panels B, C; n = 5 for panels I; n = 6 for panels (D, E, F). For panels comparing ≥3 genotype groups, statistical significance was assessed by one-way ANOVA with Dunnett’s multiple-comparisons test using vector as the reference group. For panels I and J, comparisons between DMSO and RSL3 within each genotype were assessed by unpaired two-sided Student’s t -test. Exact P -values are shown in the figure for comparisons that did not reach the threshold for asterisk annotation. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001.

Article Snippet: Lipid peroxidation was assessed using BODIPYTM 581/591 C11 (Invitrogen, Waltham, MA, USA, D3861) and Liperfluo (Dojindo, Kumamoto, Japan; L248).

Techniques: Flow Cytometry, Expressing, Plasmid Preparation, CRISPR, Fluorescence, Staining, Glo Assay